Analyzing brain tumors using advanced imaging techniques
Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis
This study is testing how advanced imaging techniques can help doctors better understand and classify gliomas, a type of brain tumor, by looking at past medical images from patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 1 Year and up |
| Sex | All |
| Sponsor | Tata Memorial Centre Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Mumbai, Maharashtra) |
| Trial ID | NCT06036381 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on gliomas, a type of primary brain tumor, by utilizing artificial intelligence and radiomic analysis of medical images such as MRI, CT, and PET scans. The research aims to identify abnormal tumor areas, classify gliomas based on prognosis, and assess treatment responses through retrospective analysis of imaging data collected from patients at Tata Memorial Centre between 2010 and 2022. By employing advanced image processing techniques, the study seeks to enhance the understanding of glioma characteristics and improve diagnostic accuracy.
Who should consider this trial
Good fit: Ideal candidates include patients with glioma or glioma-mimicking pathology who have imaging available from Tata Memorial Centre between 2010 and 2022.
Not a fit: Patients whose imaging was conducted outside Tata Memorial Centre or those with significant image artifacts may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods and treatment strategies for patients with gliomas.
How similar studies have performed: Other studies utilizing radiomic analysis and artificial intelligence in glioma characterization have shown promising results, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with glioma or glioma-mimicking pathology with imaging available in TMC between January 2010 and December 2022. Exclusion Criteria: * Imaging done outside TMC. * Motion artifacts or other artifacts causing image degradation. * Size of tumor or region of interest \< 1 cm in the largest dimension
Where this trial is running
Mumbai, Maharashtra
- Tata Memorial Hospital — Mumbai, Maharashtra, India (Recruiting)
Study contacts
- Principal investigator: Dr. ARCHYA DASGUPTA, MD — Tata Memorial Hospital
- Study coordinator: Dr. ARCHYA DASGUPTA, MD
- Email: archya1010@gmail.com
- Phone: 022-24177000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.